Novedades de la semana
Cardiovascular Risks Decline in Patients With Obesity and Autoimmune Conditions Under GLP-1 Therapy
June 8, 2026
Microbially altered bile acids and FXR receptor modulate cardiovascular risk in sleep apnea models
June 8, 2026
New Evidence Links GLP-1 Receptor Agonists to Reduced Incidence of Obesity-Related Cancers Among Non-Diabetics
June 8, 2026
Prevalence and determinants of medicinal herb usage in a rural Iranian cohort: insights from the …
June 8, 2026
Long-Term Survival Outcomes with Lorbrena Set New Standards in ALK-Positive NSCLC as Neladalkib Approaches FDA …
June 1, 2026
Single-dose gene editing shows promise in drastically lowering LDL cholesterol
June 1, 2026
Teclistamab Monotherapy Improves Survival Outcomes in Heavily Pretreated Multiple Myeloma Patients
June 1, 2026
Enhanced Survival Outcomes in Pediatric High-Risk MRD-Positive B-ALL Following CAR T-Cell Therapy
June 1, 2026
Advancing Treatment of Advanced Liposarcoma with Targeted CDK4 Inhibition
June 1, 2026
Perioperative Apalutamide and ADT Mark a Shift in Managing High-Risk Localized Prostate Cancer: Insights from …
June 1, 2026
Perioperative dual hormone therapy elevates outcomes in high-risk prostate cancer surgery
June 1, 2026
Combination Therapy Enhances Radiographic Progression-Free Survival in HRR-Mutated Metastatic Prostate Cancer
June 1, 2026
Highlights of the month
Oral RAS inhibitor daraxonrasib offers a survival breakthrough in metastatic pancreatic cancer
June 1, 2026
Adjuvant Retevmo Linked to Significant Reduction in Early-Stage RET Fusion-Positive Lung Cancer Progression
June 1, 2026
Mismatch in tissue environment may prevent pancreatic precancer lesions from becoming malignant
May 25, 2026
Access to Nature as a Strategy to Enhance Mental Health in Socioeconomically Disadvantaged Children
May 18, 2026
Artificial Intelligence in Retinal Imaging Offers New Path to Early Osteoporosis Detection
May 18, 2026
Risk of serious infections and viral reactivation in systemic lupus erythematosus patients in Japan
May 18, 2026
Targeted radiotherapy shows promise in extending control of limited metastatic breast cancer
May 18, 2026
Divergent trends in global obesity: stabilization in affluent countries versus sharp increases in developing regions
May 18, 2026
All the news
New radiotherapy regimen offers effective prostate cancer control with just two sessions and no added side effects
May 18, 2026
At the European Society for Radiotherapy and Oncology Congress (ESTRO 2026), findings from the HERMES study demonstrated that prostate cancer patients can safely receive equivalent radiotherapy doses in only two sessions over eight days without increasing side effects compared to the conventional five-session regimen. This randomized trial involved 46 men …
Read more
Effectiveness and Safety of Semaglutide for Obesity Management in Adults Over 65: Insights from Pooled STEP Trial Data
May 11, 2026
A pooled analysis of data from Novo Nordisk’s STEP clinical trials has evaluated the use of semaglutide, a glucagon-like peptide-1 receptor agonist, in individuals aged 65 years and older with obesity. This age group often faces multiple comorbidities and heightened risk for adverse events, necessitating focused study. The combined analysis …
Read more
Mitophagy-reactivating mitochondrial transplantation enhances endothelial repair in diabetic chronic wounds
May 11, 2026
Endothelial cell dysfunction driven by defective mitophagy and accumulation of damaged mitochondria is central to impaired healing in diabetic chronic wounds. While mitochondrial transplantation (MT) has shown therapeutic promise in mitochondrial damage-related conditions, its clinical translation faces challenges including suboptimal targeting and low delivery efficiency. Recent findings elucidate that MT …
Read more
Gradual Low-Dose Peanut Immunotherapy Enhances Safety and Tolerance in Allergic Preschoolers
May 11, 2026
A landmark three-year randomized trial from Sweden has shown that a gradual escalation followed by low-dose maintenance of peanut oral immunotherapy significantly improves tolerance and safety in preschool children with peanut allergy. Published in The Lancet Regional Health – Europe, the study enrolled 75 children aged 1–3 years with confirmed …
Read more
Exploring repurposed drug combinations to tackle treatment-resistant depression
May 11, 2026
Major depressive disorder remains difficult to manage in a substantial subset of patients who do not improve after multiple standard antidepressant therapies, manifesting symptoms including persistent low mood, anhedonia, reduced energy, impaired concentration, appetite changes, feelings of worthlessness, and suicidal ideation. Those failing to respond to at least two antidepressant …
Read more
Executive Function as Key Factor in Adult-Onset ADHD Symptom Severity
May 11, 2026
A recent investigation published in Frontiers in Psychiatry explored how executive functioning and environmental influences contribute to core ADHD symptoms in adults diagnosed either during childhood or adulthood. While ADHD typically begins before age 12, some adults meet diagnostic criteria without conspicuous childhood symptoms, classified as late- or adult-onset ADHD. …
Read more
Emergency Departments Bear the Visible Consequences of Broader NHS System Strains
May 11, 2026
Emergency Departments (A&E) serve as the frontline where systemic challenges within the NHS become noticeable, yet these departments are not the origin of such issues. The uncomfortable reality is that rising demand and pressures on emergency care stem from failures in other parts of the health system, including primary care, …
Read more
Emerging obesity medications may redirect responsibility toward the food industry
May 11, 2026
An essay showcased at the European Congress on Obesity in Istanbul (May 12–15) discusses how the advent of glucagon-like peptide-1 (GLP-1) receptor agonists, a new class of obesity drugs, might shift the attribution of obesity from individuals to the commercial food industry. Drawing parallels with public health successes in holding …
Read more
Glucomannan from Konjac: Enhancing Weight Management and Glycemic Stability
May 25, 2026
Konjac (Amorphophallus konjac) is a tuberous perennial plant recognized for its rich content of glucomannan, a polysaccharide notable for its high water absorption and gel-forming properties within the gastrointestinal tract. These characteristics delay gastric emptying and slow nutrient absorption, thereby extending satiety and modulating glucose and lipid diffusion. Fermentation of …
Read more
Impact of Extreme Endurance Racing on Cardiac Troponin Levels in Athletes Completing Norseman Triathlon
May 18, 2026
Cardiac troponins (cTns) serve as critical biomarkers for diagnosing suspected coronary artery disease (CAD). However, in athletes who finish ultra-endurance events such as the Norseman Xtreme Triathlon, elevations in cTns may occur independently of pathological cardiac injury. Recent research focused on the patterns of cTn changes in these athletes demonstrated …
Read more
Unveiling the challenges of sexual harassment affecting female physicians' workplace safety in Sri Lanka
May 25, 2026
Female doctors in Sri Lanka experience ongoing sexual harassment within clinical environments, a concern seldom documented across South Asia. Existing data on this issue within the medical sector remains sparse, compounded by a lack of structured procedures for reporting and addressing such misconduct. This deficiency contributes to an unsafe professional …
Read more
Ensuring patient safety through regulated follow-up of direct-to-consumer self-tests
May 25, 2026
Coombes' analysis frames the MHRA's proposals as a patient safety measure addressing the rapid growth of direct-to-consumer self-testing products. Given this market expansion, there is a critical need for refined regulatory pathways that provide accountable follow-up after test usage to maintain clinical safety and efficacy.
Read more